Advertisement
Screener

Dianthus Therapeutics, Inc. /DE/ (DNTH) Shares Outstanding

Dianthus Therapeutics, Inc. /DE/ Shares Outstanding

Dianthus Therapeutics, Inc. /DE/ (DNTH) had Shares Outstanding of 54.80 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.

Prices

us-gaap:CommonStockSharesOutstanding · last filed 2026-08-04

  • 2026-06-30: Shares outstanding (split-adjusted) 54.80M shares; Shares authorized (split-adjusted) 150.00M shares.
  • 2026-03-31: Shares outstanding (split-adjusted) 54.58M shares; Shares authorized (split-adjusted) 150.00M shares.
  • 2025-12-31: Shares outstanding (split-adjusted) 43.22M shares; Shares authorized (split-adjusted) 150.00M shares.
  • 2025-09-30: Shares outstanding (split-adjusted) 42.85M shares; Shares authorized (split-adjusted) 150.00M shares.
Period endShares outstanding (split-adjusted)Shares authorized (split-adjusted)
2026-06-3054.80M shares
10-Q · filed 2026-08-04
150.00M shares
10-Q · filed 2026-08-04
2026-03-3154.58M shares
10-Q · filed 2026-05-05
150.00M shares
10-Q · filed 2026-05-05
2025-12-3143.22M shares
10-Q · filed 2026-08-04
150.00M shares
10-Q · filed 2026-08-04
2025-09-3042.85M shares
10-Q · filed 2025-11-05
150.00M shares
10-Q · filed 2025-11-05
2025-06-3032.18M shares
10-Q · filed 2025-08-07
150.00M shares
10-Q · filed 2025-08-07
2025-03-3132.13M shares
10-Q · filed 2025-05-12
150.00M shares
10-Q · filed 2025-05-12
2024-12-3131.12M shares
10-K · filed 2026-03-09
150.00M shares
10-K · filed 2026-03-09
2024-09-3029.37M shares
10-Q · filed 2024-11-07
150.00M shares
10-Q · filed 2024-11-07
2024-06-3029.35M shares
10-Q · filed 2024-08-08
150.00M shares
10-Q · filed 2024-08-08
2024-03-3129.35M shares
10-Q · filed 2024-05-09
150.00M shares
10-Q · filed 2024-05-09
2023-12-3114.82M shares
10-K · filed 2025-03-11
150.00M shares
10-K · filed 2025-03-11
2023-09-3014.82M shares
10-Q · filed 2023-11-09
150.00M shares
10-Q · filed 2023-11-09
2023-06-3060.65M shares
10-Q · filed 2023-08-03
150.00M shares
10-Q · filed 2023-08-03
2023-03-3160.65M shares
10-Q · filed 2023-05-15
150.00M shares
10-Q · filed 2023-05-15
2022-12-31875.28K shares
10-K · filed 2024-03-21
8.72M shares
10-K · filed 2024-03-21
2022-09-3060.56M shares
10-Q · filed 2022-11-03
150.00M shares
10-Q · filed 2022-11-03
2022-06-3058.80M shares
10-Q · filed 2022-08-04
150.00M shares
10-Q · filed 2022-08-04
2022-03-3158.80M shares
10-Q · filed 2022-05-16
150.00M shares
10-Q · filed 2022-05-16
2021-12-31875.28K shares
8-K · filed 2023-12-21
3.71M shares
8-K · filed 2023-12-21
2021-09-3058.78M shares
10-Q · filed 2021-11-04
150.00M shares
10-Q · filed 2021-11-04
2021-06-3058.51M shares
10-Q · filed 2021-08-05
150.00M shares
10-Q · filed 2021-08-05
2021-03-3148.60M shares
10-Q · filed 2021-05-06
150.00M shares
10-Q · filed 2021-05-06
2020-12-3148.53M shares
10-K · filed 2022-03-08
150.00M shares
10-K · filed 2022-03-08
2020-09-3048.29M shares
10-Q · filed 2020-11-05
150.00M shares
10-Q · filed 2020-11-05
2020-06-3048.24M shares
10-Q · filed 2020-08-06
150.00M shares
10-Q · filed 2020-08-06
2020-03-3139.45M shares
10-Q · filed 2020-05-07
150.00M shares
10-Q · filed 2020-05-07
2019-12-3139.26M shares
10-K · filed 2021-03-03
150.00M shares
10-K · filed 2021-03-03
2019-09-3038.94M shares
10-Q · filed 2019-11-13
150.00M shares
10-Q · filed 2019-11-13
2019-06-3038.71M shares
10-Q · filed 2019-08-08
150.00M shares
10-Q · filed 2019-08-08
2019-03-3133.58M shares
10-Q · filed 2019-05-09
150.00M shares
10-Q · filed 2019-05-09
2018-12-3133.31M shares
10-K · filed 2020-03-03
150.00M shares
10-K · filed 2020-03-03
2018-09-3033.10M shares
10-Q · filed 2018-11-08
150.00M shares
10-Q · filed 2018-11-08
2018-06-3032.89M shares
10-Q · filed 2018-08-09
150.00M shares
10-Q · filed 2018-08-09
2018-04-30(m)85.00M shares
10-Q · filed 2018-11-08
2018-04-29(m)70.00M shares
10-Q · filed 2018-11-08
2017-12-312.35M shares
10-K · filed 2019-03-19
70.00M shares
10-K · filed 2019-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Erasca, Inc. (ERAS)United States$5.073B-19.96
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Veradermics, Inc (MANE)United States$4.839B
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51